You are here

NeuroSense Therapeutics

Biogen partner NeuroSense seeks a role in the ALS revolution

Pharma Voice

Fri, 03/1/24 - 11:24 am

NeuroSense Therapeutics

NeuroSense’s trial of ALS drug meets primary and secondary endpoints

Clinical Trials Arena

Wed, 12/6/23 - 10:22 am

NeuroSense Therapeutics

clinical trials

Biogen teams with NeuroSense to explore ALS neurofilament biomarker

BioSpace

Wed, 06/14/23 - 11:35 am

NeuroSense Therapeutics

Highlighted by Amylyx, the ALS Space is Gaining Momentum

BioSpace

Fri, 09/9/22 - 11:11 am

NeuroSense Therapeutics

BrainStorm Cell Therapeutics

FDA Clears the Way for NeuroSense's PrimeC Candidate for ALS

BioSpace

Tue, 03/22/22 - 10:46 am

NeuroSense Therapeutics